VANGUARD GROUP INC 13D and 13G filings for Niagen Bioscience Inc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-30 2:16 pm Sale | 2025-12-31 | 13G | NIAGEN BIOSCIENCE, INC. NAGE | VANGUARD GROUP INC | 3,286,498 4.110% | -735,152 (-18.28%) | Filing |
| 2025-10-31 11:03 am Purchase | 2025-09-30 | 13G | NIAGEN BIOSCIENCE, INC. NAGE | VANGUARD GROUP INC | 4,021,650 5.040% | 4,021,650 (New Position) | Filing |